Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial-Reference-Cited by-同舟云学术

Optimal priming of poxvirus vector (NYVAC)-based HIV vaccine regimens for T cell responses requires three DNA injections. Results of the randomized multicentre EV03/ANRS VAC20 Phase I/II Trial

Published:2020-06-26 Issue:6 Volume:16 Page:e1008522
ISSN:1553-7374
Container-title:PLOS Pathogens
language:en
Short-container-title:PLoS Pathog

Author:

Lévy Yves^ORCID,Lacabaratz Christine^ORCID,Ellefsen-Lavoie Kim,Stöhr Wolfgang,Lelièvre Jean-Daniel,Bart Pierre-Alexandre,Launay Odile,Weber Jonathan,Salzberger Bernd,Wiedemann Aurélie^ORCID,Surenaud Mathieu^ORCID,Koelle David M.,Wolf Hans,Wagner Ralf,Rieux Véronique,Montefiori David C.^ORCID,Yates Nicole L.^ORCID,Tomaras Georgia D.,Gottardo Raphael,Mayer Bryan^ORCID,Ding Song,Thiébaut Rodolphe,McCormack Sheena,Chêne Geneviève,Pantaleo Giuseppe

Publisher

Public Library of Science (PLoS)

Subject

Virology,Genetics,Molecular Biology,Immunology,Microbiology,Parasitology

Reference47 articles.

1. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand;S Rerks-Ngarm;The New England Journal of Medicine,2009

2. Is an HIV vaccine possible?;AJ McMichael;Nat Med,1999

3. Cellular immune responses to HIV;AJ McMichael;Nature,2001

4. HIV-1 prophylactic vaccines: state of the art;JD Lelievre;J Virus Erad,2016

5. A phase IIA randomized clinical trial of a multiclade HIV-1 DNA prime followed by a multiclade rAd5 HIV-1 vaccine boost in healthy adults (HVTN204);GJ Churchyard;PLoS One,2011

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rendezvous with Vaccinia Virus in the Post-smallpox Era: R&D Advances;Viruses;2023-08-15

2. Highly Attenuated Poxvirus-Based Vaccines Against Emerging Viral Diseases;Journal of Molecular Biology;2023-08

3. Rapid Construction of an Infectious Clone of Fowl Adenovirus Serotype 4 Isolate;Viruses;2023-07-29

4. Early and Long-Term HIV-1 Immunogenicity Induced in Macaques by the Combined Administration of DNA, NYVAC and Env Protein-Based Vaccine Candidates: The AUP512 Study;Frontiers in Immunology;2022-07-22

5. T Cell Immunogenicity, Gene Expression Profile, and Safety of Four Heterologous Prime-Boost Combinations of HIV Vaccine Candidates in Healthy Volunteers: Results of the Randomized Multi-Arm Phase I/II ANRS VRI01 Trial;The Journal of Immunology;2022-06-15